Amphotericin B-deoxycholate overdose due to administration error in pediatric patients
Open Access
- 1 January 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 46 (2) , 185-187
Abstract
Due to the similarity of their generic names, the use of amphotericin B-deoxycholate and liposomal amphotericin B could cause confusion in daily practice. We report two cases of amphotericin B-deoxycholate overdose in infants due to administration errors which raises the issue that the use of this antifungal agent should be questioned because of its severe side effects.Keywords
This publication has 5 references indexed in Scilit:
- Fatal Overdose of Amphotericin B in Two Preterm InfantsDevelopmental Pharmacology and Therapeutics, 2017
- What is the current and future status of conventional amphotericin B?International Journal of Antimicrobial Agents, 2006
- Fatal Amphotericin B Overdose Due to Administration of Nonlipid Formulation Instead of Lipid FormulationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Hyperkalemia Associated with Rapid Infusion of Conventional and Lipid Complex Formulations of Amphotericin BPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
- Amphotericin B Overdose in Pediatric Patients with Associated Cardiac ArrestAnnals of Pharmacotherapy, 1993